Cargando…
Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency
Spinal muscular atrophy (SMA) is a spectrum of genetically and clinically heterogeneous diseases leading to the progressive degeneration of peripheric motor neurons with subsequent muscle weakness and atrophy. More than 95% of the cases of SMA are represented by homozygous mutations of the SMN1 gene...
Autores principales: | Axente, Mihaela, Shelby, Elena-Silvia, Mirea, Andrada, Sporea, Corina, Badina, Mihaela, Padure, Liliana, Ion, Daniela Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321613/ https://www.ncbi.nlm.nih.gov/pubmed/34377212 http://dx.doi.org/10.25122/jml-2021-0147 |
Ejemplares similares
-
Combination Therapy with Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type I
por: Mirea, Andrada, et al.
Publicado: (2021) -
Clinical and Electrophysiological Changes in Pediatric Spinal Muscular Atrophy after 2 Years of Nusinersen Treatment
por: Axente, Mihaela, et al.
Publicado: (2022) -
Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy
por: Badina, Mihaela, et al.
Publicado: (2023) -
Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency
por: Nagree, Murtaza S., et al.
Publicado: (2023) -
Expanding the Clinical Phenotype of 19q Interstitial Deletions: A New Case with 19q13.32-q13.33 Deletion and Short Review of the Literature
por: Shelby, Elena-Silvia, et al.
Publicado: (2022)